Green Leaf Scientific, has added US-based Diagnostic Biochips to its product offering. DBC
develops and manufactures high-density silicon probes for single-unit recordings of neurons
in freely-behaving animals. Its open-source platform ensures easy connections to any third
party electrophysiology system, while cloud-based analysis software integration eases data
sharing among neuroscientists.
About Diagnostic Biochips Inc
Diagnostic Biochips (DBC) is making brain diagnostics more cost-effective and accessible to
academic, research and medical communities. DBC is accelerating the development and application
of innovative technologies by providing access to brain data and advancing neuroscience to enable
therapies and cures for neurological disorders and diseases. Researchers will be able to produce a
revolutionary new picture of the brain that, for the first time, shows how individual cells and
complex neural circuits interact in both time and space. DBS was founded in 2013 and has been
continually expanding its neurosensory capabilities. DBS is based in Glen Burnie, Maryland, USA with
a regional sales office in Austin, Texas, USA and now with representation in Europe through Green
Leaf Scientific. www.diagnosticbiochips.com
